Tags

Type your tag names separated by a space and hit enter

Quality assurance: protocol for assessing the rifampicin bioavailability of combined formulations in healthy volunteers.
Int J Tuberc Lung Dis. 1999 Nov; 3(11 Suppl 3):S284-5.IJ

Pub Type(s)

Journal Article

Language

eng

PubMed ID

10593705

Citation

"Quality Assurance: Protocol for Assessing the Rifampicin Bioavailability of Combined Formulations in Healthy Volunteers." The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease, vol. 3, no. 11 Suppl 3, 1999, pp. S284-5.
Quality assurance: protocol for assessing the rifampicin bioavailability of combined formulations in healthy volunteers. Int J Tuberc Lung Dis. 1999;3(11 Suppl 3):S284-5.
(1999). Quality assurance: protocol for assessing the rifampicin bioavailability of combined formulations in healthy volunteers. The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease, 3(11 Suppl 3), S284-5.
Quality Assurance: Protocol for Assessing the Rifampicin Bioavailability of Combined Formulations in Healthy Volunteers. Int J Tuberc Lung Dis. 1999;3(11 Suppl 3):S284-5. PubMed PMID: 10593705.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Quality assurance: protocol for assessing the rifampicin bioavailability of combined formulations in healthy volunteers. PY - 1999/12/11/pubmed PY - 1999/12/11/medline PY - 1999/12/11/entrez SP - S284 EP - 5 JF - The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease JO - Int J Tuberc Lung Dis VL - 3 IS - 11 Suppl 3 SN - 1027-3719 UR - https://www.unboundmedicine.com/medline/citation/10593705/Quality_assurance:_protocol_for_assessing_the_rifampicin_bioavailability_of_combined_formulations_in_healthy_volunteers_ DB - PRIME DP - Unbound Medicine ER -